La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Avalon Globocare a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Avalon Globocare..

Avalon Globocare (NASDAQ:ALBT) Azioni, Catena delle Opzioni

Avalon Globocare

Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment which is the key revenue driver; medical-related consulting services segment. It focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.

Avalon Globocare Corp

AllianceBlock - United States Dollar

Assured Guaranty (AG)&#x2A; has insured $920 million of senior Special Facilities Revenue Bonds issued by the New York Transportation Development Corporation in connection with the JFK Airport Terminal 6 Redevelopment Project. The insured bonds were issued on November 5 as part of an upsized $1.95 billion offering and included $820 million of Series 2024A (Green Bonds) (AMT) fixed rate, current interest bonds with a maturity in 2054 and approximately $100 million of Series 2024B (AMT) fixed rate convertible capital appreciation bonds with a maturity in 2054.
The bonds were issued to refinance part of JFK Millennium Partners' (JMP) short term 2022A bonds and bank loans that were used to finance its redevelopment project, which will replace former Terminal 6 and 7 with a new world-class, 1.2 million square foot Terminal 6 with sustainable and innovative technology. JMP is a consortium established by Vantage Group, American Triple I, RXR Realty and JetBlue Airways.

News

Financing

Assured Guaranty Insures $920M Of Bonds As Part Of $1.95B JFK Airport Terminal 6 Redevelopment Project

Dividends

MCHP

Microchip Raises Dividend From $0.454 To $0.455

HeartCore Enterprises, Inc. (NASDAQ:<a href="https://www.benzinga.com/stock/HTCR#NASDAQ">HTCR</a>) ("HeartCore" or "the Company"), a leading enterprise software and data consulting services company based in Tokyo, announced today that it has received written notice from the Nasdaq Stock Market LLC that the Company demonstrated compliance with the $1.00 minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) (the "Minimum Bid Price Requirement") and that the Company is therefore in compliance with the Nasdaq Capital Market's listing requirements. As a result, the Company's securities will continue to be listed and traded on The Nasdaq Stock Market.

HTCR

HeartCore Regains Compliance With Nasdaq Listing Requirements

WIIM

EOSE

Eos Energy Enterprises shares are trading lower after the company reported Q3 financial results and cut its FY24 revenue guidance.

Blend (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLND#NYSE">BLND</a>), the leading origination platform for digital banking solutions, and Covered Insurance Solutions (Covered), a premier provider of embedded insurance solutions, have announced a new strategic partnership to further streamline the home insurance shopping experience.

BLND

Blend And Covered Insurance Announce New Strategic Partnership To Streamline Home Insurance Shopping

She succeeds Robert Wood, previous Chairman of the Board, who has retired from the board for personal reasons.&nbsp;

Management

MRC Global Names Deborah Adams As Its New Board Chair, Effective Immediately

Bristow Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VTOL#NYSE">VTOL</a>) affirms FY2026 sales outlook from $1.52 billion-1.77 billion to $1.52 billion-1.77 billion.

Guidance

VTOL

Bristow Group Affirms FY2026 Sales Guidance from $1.52B-1.77B to $1.52B-1.77B

Bristow Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VTOL#NYSE">VTOL</a>) affirms FY2025 sales outlook from $1.44 billion-1.61 billion to $1.44 billion-1.61 billion.

Bristow Group Affirms FY2025 Sales Guidance from $1.44B-1.61B to $1.44B-1.61B

CYTK

Cytek Biosciences shares are trading higher following better-than-expected Q3 earnings.

Bristow Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VTOL#NYSE">VTOL</a>) narrows FY2024 sales outlook from $1.35 billion-1.42 billion to $1.35 billion-1.41 billion.

Bristow Group Narrows FY2024 Sales Guidance from $1.35B-1.42B to $1.35B-1.41B

Arteris (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIP#NASDAQ">AIP</a>) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0.12) by 33.33 percent. This is a 33.33 percent increase over losses of $(0.12) per share from the same period last year. The company reported quarterly sales of $14.71 million which met the analyst consensus estimate. This is a 10.84 percent increase over sales of $13.27 million the same period last year.

Earnings

Earnings Beats

Arteris Q3 Adj $(0.08) Beats $(0.12) Estimate, Sales $14.71M Inline

Safety Insurance Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAFT#NASDAQ">SAFT</a>) reported quarterly earnings of $1.10 per share which missed the analyst consensus estimate of $1.40 by 21.43 percent. This is a 86.44 percent increase over earnings of $0.59 per share from the same period last year. The company reported $295.28 million in sales this quarter. This is a 28.74 percent increase over sales of $229.36 million the same period last year.

Earnings Misses

SAFT

Safety Insurance Group Q3 EPS $1.10 Misses $1.40 Estimate, Sales $295.28M Up From $229.36M YoY

Select Water Solutions (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WTTR#NYSE">WTTR</a>) reported quarterly earnings of $0.15 per share which met the analyst consensus estimate. The company reported quarterly sales of $371.349 million which beat the analyst consensus estimate of $350.908 million by 5.83 percent. This is a 4.60 percent decrease over sales of $389.273 million the same period last year.

WTTR

Select Water Solutions Q3 2024 GAAP EPS $0.15, Inline, Sales $371.349M Beat $350.908M Estimate

Mayville Engineering (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MEC#NYSE">MEC</a>) reported quarterly earnings of $0.21 per share which met the analyst consensus estimate. This is unchanged from the same period last year. The company reported quarterly sales of $135.392 million which missed the analyst consensus estimate of $157.606 million by 14.09 percent. This is a 14.43 percent decrease over sales of $158.217 million the same period last year.

Mayville Engineering Q3 2024 Adj. EPS $0.21, Inline, Sales $135.392M Miss $157.606M Estimate

LoanDepot shares are trading higher after the company reported better-than-expected Q3 financial results.

Limbach Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LMB#NASDAQ">LMB</a>) raises FY2024 sales outlook from $515.00 million-535.00 million to $520.00 million-540.00 million.

Limbach Holdings Raises FY2024 Sales Guidance from $515.00M-535.00M to $520.00M-540.00M  VS Est. 519.25M

UFCS

United Fire Group shares are trading higher after the company reported better-than-expected Q3 financial results.

BBAI

BigBear.ai shares are trading lower after the company reported worse-than-expected Q3 revenue results.

Helios Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HLIO#NYSE">HLIO</a>) reported quarterly earnings of $0.59 per share which beat the analyst consensus estimate of $0.54 by 9.26 percent. This is a 34.09 percent increase over earnings of $0.44 per share from the same period last year. The company reported quarterly sales of $194.500 million which missed the analyst consensus estimate of $196.574 million by 1.06 percent. This is a 3.43 percent decrease over sales of $201.400 million the same period last year.

HLIO

Helios Technologies Q3 2024 Adj. EPS $0.59 Beats $0.54 Estimate, Sales $194.500M Miss $196.574M Estimate

2024 ANNUAL GUIDANCE(1)
NOG is reiterating capital expenditure and production guidance and adjusting certain line items. Production taxes are being adjusted to reflect current expectations for the remainder of the year. Natural gas realizations and oil differentials are being adjusted to reflect results experienced year-to-date. Per unit cash G&amp;A is being lowered as the Company has reduced certain external expenses and continues to benefit from increasing production volumes.
<figure class="table"> 
<table>
<tbody>
<tr>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">Prior Guidance</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">Revised Guidance</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Annual Production (Boe per day)</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">120,000 - 124,000</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">120,000 - 124,000</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Annual Oil Production (Bbls per day)</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">73,000 - 76,000</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">73,000 - 76,000</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Total Capital Expenditures ($ in millions)</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$890 - $970</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$890 - $970</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Net Wells Turned-in-Line ("TIL")</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">93.0 - 98.0</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">93.0 - 98.0</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Net Wells Spud</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">73.0 - 78.0</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">73.0 - 78.0</td>
</tr>
<tr>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Operating Expenses and Differentials:</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Production Expenses (per Boe)</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$9.15 - $9.40</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$9.15 - $9.40</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Production Taxes (as a percentage of Oil &amp; Gas Sales)</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">9.0% - 9.5%</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">8.5% - 9.0%(2)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Average Differential to NYMEX WTI (per Bbl)</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">($4.00) - ($4.85)</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">($4.00) - ($4.50)</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Average Realization as a Percentage of NYMEX Henry Hub (per Mcf)</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">87.5% - 92.5%</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">90.0% - 95.0%</td>
</tr>
<tr>
<td colspan="1" rowspan="1">DD&amp;A Rate (per Boe)</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$16.50 - $17.50</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$16.50 - $17.50</td>
</tr>
</tbody>
</table>
</figure>

NOG Reiterates Capital Expenditure And Production Guidance

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Avalon Globocare (NASDAQ:<a href="https://investorplace.com/stock-quotes/albt-stock-quote/">ALBT</a>) just reported results for the second quarter of 2024.<ul><li>Avalon Globocare reported earnings per share of -19 cents.</li><li>The company reported revenue of $327,887.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>The post <a href="https://investorplace.com/earning-results/2024/08/albt-stock-earnings-avalon-globocare-for-q2-of-2024/">ALBT Stock Earnings: Avalon Globocare Reported Results for Q2 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

ALBT Stock Earnings: Avalon Globocare Reported Results for Q2 2024

Real estate stocks start one of the worst months for equities on a strong note

Avalon GloboCare ( ($ALBT) ) has provided an update. Avalon GloboCare Corp., a Delaware-based company specializing in precision diagnostics and lab...

Avalon GloboCare Showcases KetoAir™ at Keto Conference

Avalon GloboCare ( ($ALBT) ) just unveiled an announcement. Avalon GloboCare Corp. has announced a strategic 1-for-15 reverse stock split effective...

Avalon GloboCare Announces Reverse Stock Split Strategy

Avalon (ALBT) GloboCare announced that it will effect a 1-for-15 reverse split of its common shares that will become effective on October 28, 2024....

Avalon announces 1-for-15 reverse stock split

An update from Avalon GloboCare ( ($ALBT) ) is now available. Avalon GloboCare Corp. has announced a strategic collaboration with Qi Diagnostics Li...

Avalon GloboCare Collaborates for Cannabis Breathalyzer Development

Avalon (ALBT) GloboCare announced that it entered into a memorandum of understanding, MOE,with Qi Diagnostics Limited), a nanosensor-based diagnost...

Avalon, enters MOU with Qi Diagnostics

19:50 EDT Avalon (ALBT) Globocare Corp trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-moving br...

Avalon Globocare Corp trading halted, news pending

These are the upcoming stock splits for the week of October 28 to November 1, based on&nbsp;TipRanks' Stock Splits Calendar. A stock split is a cor...

Upcoming Stock Splits This Week (October 28 to November 1) – Stay Invested

Avalon GloboCare ( ($ALBT) ) just unveiled an announcement. Avalon GloboCare has appointed Dr. Charles Cavo to its Scientific and Clinical Advisory...

Avalon GloboCare Appoints Dr. Cavo to Advisory Board

ALBT

BBRE

CBRE

CSGP

DFAR

EQIX

FREL

INDS

INVH

JPRE

KBWY

KZIA

MORT

MOVE

NETL

NURE

PPTY

REIT

ROOF

RSPR

SBAC

SCHH

SPRE

SRVR

SVRE

TRNO

USRT

VICI

WELL

WHLR

XLRE

Press Releases

MAIA Biotechnology (MAIA) to Showcase Groundbreaking Telomere-Targeting Cancer Treatments at BIO International Convention 2024

Health Care

General

Avalon GloboCare Provides Update on the Launch of the KetoAir Breathalyzer at Hack Your Health by KetoCon 2024 Conference

Avalon GloboCare Launches Online Sales of KetoAir Breathalyzer in the U.S. at Ketoair.us

Avalon's Laboratory Services MSO Launches DNA Testing Kit for Predisposition to Opioid Addiction

Avalon's Laboratory Services MSO to Launch Sales of Proprietary FDA-Registered External Male Catheter Device

Avalon GloboCare to Sponsor Keto Pa-LOU-za 2024 Conference and Showcase KetoAir Breathalyzer Device

Avalon GloboCare Announces 1-for-15 Reverse Stock Split as Part of Nasdaq Compliance Plan

Avalon GloboCare and Qi Diagnostics Enter into Memorandum of Understanding for Proposed Co-Development of Real-Time Cannabis Breathalyzer for Detecting Potential Impaired Driving

Avalon GloboCare Appoints Dr. Charles Cavo to its Scientific Advisory Board in Support of KetoAir Sales

"Trump Media (NASDAQ: DJT) Surges on Election Day as SmallCap Stocks CRDL, ALBT, ZVSA, PRSO Emerge"

AFMD

BPTH

CRDL

FEDU

GPCR

MAIA

MBOT

PRSO

ZVSA

American Realty Investors, Inc. Common Stock

American Realty Investors

FRP Holdings

New Concept Energy

The Intergroup Corporation - Common Stock

Intergroup

IRSA Inversiones Y Representaciones S.A. Global Depositary Shares (Each representing ten shares of Common Stock)

IRSA Inversiones y

Kennedy-Wilson Holdings Inc. Common Stock

Kennedy-Wilson Holdings

LandBridge Company LLC Class A Shares Representing Limited Liability Company Interests

LandBridge

Logistic Properties of the Americas Ordinary Shares

Logistic Properties

LuxUrban Hotels

J. W. Mays

Murano Global Investments PLC - Ordinary Shares

Murano Global Investments

New England Realty Associates Limited Partnership Class A Depositary Receipts Evidencing Units of Limited Partnership

New England Realty

American Strategic Investment Co. Class A Common Stock

American Strategic

Belpointe PREP

Rafael Holdings, Inc. Class B Common Stock

Rafael Holdings

Reitar Logtech Holdings Limited - Ordinary shares

Reitar Logtech Holdings

Seaport Entertainment Group Inc. Common Stock

Seaport Entertainment

Seritage Growth Properties Class A Common Stock

Seritage Growth Props

Transcontinental Realty Investors, Inc. Common Stock

Transcontinental Realty

Corporacion Inmobiliaria Vesta, S.A.B de C.V. American Depositary Shares, each representing ten (10) Common Shares

Comments

Avalon Globocare

Avalon Globocare (ALBT) Opzioni

No option chain data available. Please try again later

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO